Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Interleukin 2: Biology and biochemistry

Abstract

Since its discovery as a T-cell growth factor, interleukin 2 (IL-2) has attracted considerable scientific attention, not only as a useful reagent for the maintenance of large numbers of effector T lymphocytes but as a potentially potent immunoregulatory molecule, which could be of therapeutic usefulness in a number of clinical conditions. Outlined in this communication is a summary of the more salient biochemical features of murine and human IL-2, as well as the results of initial molecular biology experimentation aimed at the eventual production of IL-2 by recombinant DNA methodologies. These studies, together with those detailing thein vivo effectiveness of IL-2 therapy in a number of murine model situations, provide a current glimpse of future IL-2 aims and directions.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    deWeck AL, Kristensen F, Landy M (eds): Biochemical Characterization of Lymphokines. Proceedings of the Second International Lymphokine Workshop. New York, Academic Press, 1980

  2. 2.

    Adamson JW, Popovic WJ, Brown JE: Hormonal control of erythropoiesis.In Hematopoietic Cell Differentiation, DW Golde, MJ Cline, D Metcalf, CF Fox (eds). New York, Academic Press, 1978, p 53

  3. 3.

    Burgess AW, Metcalf D, Nicola NA, Russel SHM: Purification and characterization of cell specific colony stimulating factors.In Hematopoietic Cell Differentiation, DW Golde, MJ Cline, D Metcalf, CF Fox (eds). New York, Academic Press, 1978, p 399

  4. 4.

    Yung YP, Eger R, Tertian G, Moore MAS: Long-termin vitro culture of murine mast cells. II. Purification of a mast cell growth factor and its dissociation from TCGF. J Immunol 127:794, 1981

  5. 5.

    Morgan DA, Ruscetti FW, Gallo RC: Selectivein vitro growth of T lymphocytes from normal human bone marrows. Science 193:1007, 1976

  6. 6.

    Ruscetti FW, Morgan DA, Gallo RC: Functional and morphological characterization of human T cells continuously grownin vitro. J Immunol 122:2527, 1979

  7. 7.

    Gillis S, Smith KA: Long term culture of tumor-specific cytotoxic T cells. Nature (Lond) 268:154, 1977

  8. 8.

    Gillis S, Baker PE, Ruscetti FW, Smith KA: Long-term culture of human antigen-specific cytotoxic T cell lines. J Exp Med 154:983, 1978

  9. 9.

    Baker PE, Gillis S, Smith KA: Monoclonal cytotoxic T cell lines. J Exp Med 149:273, 1979

  10. 10.

    Nabholz M, Enger HD, Collavo D, North M: Cloned T cell lines with specific cytolytic activity. Curr Top Microbiol Immunol 81:176, 1978

  11. 11.

    Rosenberg SA, Schwarz S, Spiess PJ:In vitro growth of murine T cells. II. Growth ofin vitro sensitized cells cytotoxic for alloantigens. J Immunol 121:1951, 1978

  12. 12.

    Schreir MH, Tees R: Clonal induction of helper T cells: Conversion of specific into non-specific signals. Int Arch Allergy Appl Immunol 61:227, 1980

  13. 13.

    Watson J: Continuous proliferation of murine antigen-specific helper T cells in culture. J Exp Med 150:1510, 1979

  14. 14.

    Strausser JL, Rosenberg SA:In vitro growth of cytotoxic human lymphocytes. I. Growth of cells sensitizedin vitro to alloantigens. J Immunol 121:1491, 1978

  15. 15.

    Aarden LA: Revised nomenclature for antigen-nonspecific T cell proliferation and helper factors. J Immunol 123:2928, 1979

  16. 16.

    Watson J, Gillis S, Marbrook J, Mochizuki D, Smith L: Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines. J Exp Med 150:849, 1979

  17. 17.

    Gillis S, Union NA, Baker PE, Smith KA: Thein vitro generation and sustained culture of nude mouse cytolytic T-lymphocytes. J Exp Med 149:1460, 1979

  18. 18.

    Gillis S, Smith KA, Watson JD: Biochemical and biological characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines. J Immunol 124:1954, 1980

  19. 19.

    Gillis S, Ferm MM, Ou W, Smith KA: T cell growth factor: Parameters of production and a quantitative microassay for activity. J Immunol 120:2027, 1978

  20. 20.

    Gillis S, Scheid M, Watson J: The biochemical and biological characterization of lymphocyte regulatory molecules. III. The isolation and phenotypic characterization of interleukin 2 producing T cell lymphomas. J Immunol 125:2570, 1980

  21. 21.

    Gillis S, Watson J: Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2 producer human leukemia T cell line. J Exp Med 152:1709, 1980

  22. 22.

    Durdik JM, Beck BN, Henney CS: The use of lymphoma cell variants differing in their susceptibility to NK cell mediated lysis to analyze NK cell-target cell interactions.In Natural Cell-Mediated Immunity Against Tumors, RB Herberman (ed). New York, Academic Press, 1980

  23. 23.

    Okada M, Henney CS: The differentiation of cytotoxic T cellsin vitro. II. Amplifying factor(s) produced in primary mixed lymphocyte cultures against K/D stimuli require the presence of Lyt 2+ cells but not Lyt 1+ cells. J Immunol 125:300, 1980

  24. 24.

    Young WW, Hakomori S, Durdik JM, Henney CS: Identification of ganglio-N-tetraosylceramide as a new cell surface marker for murine natural killer (NK) cells. J Immunol 124:199, 1980

  25. 25.

    Gillis S, Smith KA:In vitro generation of tumor-specific cytotoxic lymphocytes. Secondary allogeneic mixed tumorlymphocyte culture of normal murine spleen cells. J Exp Med 146:468, 1977

  26. 26.

    Smith KA, Gillis S, Baker PE, McKenzie D, Ruscetti FW: T cell growth factor-mediated T cell proliferation. Proc NY Acad Sci 332:423, 1979

  27. 27.

    Larsson EL, Iscove NN, Coutinho A: Two distinct factors are required for induction of T cell growth. Nature (Lond) 283:664, 1980

  28. 28.

    Smith KA, Lachman LB, Oppenheim JJ, Favata MF: The functional relationship of the interleukins. J Exp Med 151:1551, 1980

  29. 29.

    Mochizuki DY, Watson J, Gillis S: The biochemical and biological characterization of lymphocyte regulatory molecules. IV. Purification of interleukin 2 from a murine T cell lymphoma. J Immunol 125:2579, 1980

  30. 30.

    Frank MB, Mochizuki DY, Watson T, Gillis S: Biochemical and biological characterization of lymphocyte regulatory molecules. VIII. Purification of interleukin 2 from a human leukemia T-cell line. J Immunol 127:2361, 1981

  31. 31.

    Mochizuki DY, Watson J, Gillis S: Biochemical separation of interleukin 2. J Immunol Methods 39:185, 1980

  32. 32.

    Bleackley RC, Caplan B, Havele CR, Ritzel G, Mosmann TR, Farrar JJ, Paetkau V: Translation of lymphocyte mRNA into biologically-active interleukin 2 in oocytes. J Immunol 127:2432, 1982

  33. 33.

    Chirgwin JM, Pryzbyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294, 1979

  34. 34.

    O'Farrell P: High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250:4007, 1975

  35. 35.

    Pelham HRB, Jackson RJ: An efficient mRNA-dependent translation system from reticulocyte lysates. Eur J Biochem 67:247, 1976

  36. 36.

    Henney CS: Quantitation of the cell-mediated immune response. I. The number of cytolytically active mouse lymphoid cells induced by immunization with allogeneic mastocytoma cells. J Immunol 107:1558, 1971

  37. 37.

    Henney CS, Kuribaysashi K, Kern DE, Gillis S: Interleukin-2 augments natural killer cell activity. Nature (Lond) 291:335, 1981

  38. 38.

    Minato N, Reid L, Bloom BR: On the heterogeneity of murine natural killer cells. J Exp Med 154:750, 1981

  39. 39.

    Hefeneider SH, Conlon PJ, Henney CS, Gillis S:In vitro interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells. J Immunol (in press), 1983

  40. 40.

    Gillis S, Mizel SB: T cell lymphoma model for the analysis of Interleukin 1 mediated T-cell activation. Proc Natl Acad Sci USA 78:1133, 1981

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Gillis, S. Interleukin 2: Biology and biochemistry. J Clin Immunol 3, 1–13 (1983). https://doi.org/10.1007/BF00919133

Download citation

Key words

  • Interleukin 2
  • biological response modifier
  • lymphokines